Capricor Therapeutics, Inc. Appoints Thomas Copmann as Vice President of Regulatory Affairs and Drug Development
manage reporting to the FDA and health authorities. Prior to joining Capricor, Dr. Copmann served as chair of the Commission on Drugs for Rare Diseases, was the industry representative on the National Vaccine Advisory Board and served as a scientific advisor to President George H.W. Bush.